Drug General Information
Drug ID	D0G5YI
Former ID	DNC006598
Drug Name	Di(1H-indol-2-yl)methanone
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528209]
Structure		Download 2D MOL 3D MOL
Formula	C17H12N2O
Canonical SMILES	C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=CC=CC=C4N3
InChI	1S/C17H12N2O/c20-17(15-9-11-5-1-3-7-13(11)18-15)16-10-12-6-2-4-8-14(12)19-16/h1-10,18-19H
InChIKey	GQJIQKLWZMQQGO-UHFFFAOYSA-N
PubChem Compound ID	10220822
Target and Pathway
Target(s)	Alpha platelet-derived growth factor receptor	Target Info	Inhibitor	[528209]
	FL cytokine receptor	Target Info	Inhibitor	[528209]
	Beta platelet-derived growth factor receptor	Target Info	Inhibitor	[528209]
KEGG Pathway	MAPK signaling pathway
	Ras signaling pathway
	Rap1 signaling pathway
	Calcium signaling pathway
	Cytokine-cytokine receptor interaction
	Endocytosis
	PI3K-Akt signaling pathway
	Focal adhesion
	Gap junction
	Regulation of actin cytoskeleton
	HTLV-I infection
	Pathways in cancer
	MicroRNAs in cancer
	Glioma
	Prostate cancer
	Melanoma
	Central carbon metabolism in cancer
	Choline metabolism in cancerhsa04060:Cytokine-cytokine receptor interaction
	Hematopoietic cell lineage
	Transcriptional misregulation in cancer
	Acute myeloid leukemia
	Central carbon metabolism in cancerhsa04010:MAPK signaling pathway
	Choline metabolism in cancer
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
PANTHER Pathway	Angiogenesis
	PDGF signaling pathwayP00005:Angiogenesis
	PDGF signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
	PDGFR-alpha signaling pathway
	PDGF receptor signaling networkptp1bpathway:Signaling events mediated by PTP1B
	Beta3 integrin cell surface interactions
	S1P3 pathway
	Nectin adhesion pathway
	Signaling events mediated by TCPTP
	SHP2 signaling
	S1P1 pathway
	Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
	PDGFR-beta signaling pathway
	Validated targets of C-MYC transcriptional repression
	PDGF receptor signaling network
Reactome	PIP3 activates AKT signaling
	Constitutive Signaling by Aberrant PI3K in Cancer
	RAF/MAP kinase cascadeR-HSA-1257604:PIP3 activates AKT signaling
	RAF/MAP kinase cascade
WikiPathways	Regulation of Actin Cytoskeleton
	Osteoblast Signaling
	Focal Adhesion
	Hair Follicle Development: Organogenesis (Part 2 of 3)
	PIP3 activates AKT signaling
	Cardiac Progenitor Differentiation
	Integrated Pancreatic Cancer Pathway
	Allograft Rejection
	Signaling Pathways in Glioblastoma
	Signaling by PDGF
	AngiogenesisWP51:Regulation of Actin Cytoskeleton
	MAPK Signaling Pathway
	PDGF Pathway
References
Ref 528209	J Med Chem. 2006 Jun 1;49(11):3101-15.Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
Ref 528209	J Med Chem. 2006 Jun 1;49(11):3101-15.Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.